Estrella Immunopharma

Estrella Immunopharma(ESLAW)

EMERYVILLE, CA
Pharmaceutical

Focus: Combining CD19-Redirected ARTEMIS T Cells with cancer-labeling technology

Estrella Immunopharma is a life sciences company focused on Combining CD19-Redirected ARTEMIS T Cells with cancer-labeling technology.

Oncology
Funding Stage
PUBLIC
Open Jobs
0

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
SEC Filings: 2 available

Financials (FY2024)

R&D Spend
$10M
Net Income
-$11M
Cash
$2M